YOLFTbeta
Inspecs Group plc

Inspecs Group plc

SPEC · LSE · Healthcare / Medical Instruments & Supplies

87.50GBX+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close87.50
Open87.50
Day Range85.00 – 87.50
52-Week Range40.00 – 105.00
Volume475
Market Cap99.89M
P/E (TTM)0.00
Forward P/E11.36
EPS-0.04
Dividend Yield0.00%
Beta1.61
50-Day Avg95.67
200-Day Avg86.08

About

INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia. It operates through Frames and Optics product distribution and Manufacturing segments. The company offers its products under the retail brands, such as Barbour, Barbour International, BUFFALO David Bitton, CAT, Free Country, Henri-Lloyd, Hype, JOSEPH, Lamb, Liberty, Lyle & Scott, Marc O'Polo, MINI, O'Neill, RADLEY, Superdry & Co, TALBOT RUNHOF, Ted Baker, and VIKTOR & ROLF and in house brands under BOTANIQ, SAVILE ROW Titanium, SAVILE ROW, BRENDEL Eyewear, FREIGEIST, HUMPHREY'S eyewear, JOS ESCHENBACH, and TITANFLEX names. INSPECS Group plc was founded in 1988 and is based in Bath, United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Richard Charles Peck
  • Employees1.66K
  • Headquarters7-10 Kelso Place, Bath, United Kingdom, BA1 3AU, UK
  • Websitehttps://www.inspecs.com

Leadership

  • Mr. Robin Bjorn Christian TottermanFounder & Executive Chairman · b. 1960
  • Mr. Richard Charles PeckGroup CEO & Executive Director · b. 1964
  • Mr. Christopher David KayChief Financial Officer · b. 1963
  • Martin BatesSales Director
  • Mr. Steve TulbaManaging Director of Inspecs Division
  • Nick YouleHead of Innovations
  • Angela EmanGroup ESG, Compliance & Risk Officer
  • Elliott Martin Glynn SmithSecretary

Financials

Income Statement

Currency: GBP2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue22.09M49.17M54.43M61.25M34.79M182.62M200.96M203.29M198.26M191.70M
Growth (%)-+122.58%+10.69%+12.53%-43.19%+424.90%+10.04%+1.16%-2.48%-3.31%
Cost of Revenue13.48M27.64M31.39M33.71M26.89M96.84M102.10M99.75M94.81M104.33M
Gross Profit8.62M21.53M25.90M27.54M20.52M85.78M98.86M103.55M103.45M87.37M
Gross Margin39.00%43.79%47.58%44.96%58.99%46.97%49.19%50.94%52.18%45.58%
Operating Expense7.71M17.17M17.89M19.59M22.68M84.64M100.05M100.66M100.04M81.69M
Operating Income906.05K4.37M8.01M7.95M-2.16M1.14M-1.19M2.89M3.41M5.68M
Operating Margin4.10%8.88%14.72%12.97%-6.20%0.63%-0.59%1.42%1.72%2.97%
EBITDA1.24M2.48M10.87M8.82M-4.86M6.05M8.28M17.27M15.75M17.49M
EBITDA Margin5.60%5.05%19.97%14.40%-13.97%3.31%4.12%8.50%7.94%9.12%
Net Income574.37K-2.47M3.32M4.91M-6.54M-4.03M-6.32M-997.00K-4.61M-6.51M
Net Income Margin2.60%-5.03%6.11%8.02%-18.80%-2.21%-3.14%-0.49%-2.32%-3.40%
Interest Expense327.93K1.37M1.33M1.39M1.99M2.72M2.31M4.16M3.96M3.15M
Interest Expense % of Total Revenue1.48%2.78%2.44%2.26%5.73%1.49%1.15%2.04%1.99%1.64%

Balance Sheet

Currency: GBP2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets14.33M69.75M69.33M71.38M310.45M326.36M292.68M221.91M220.25M202.23M
Total Liabilities12.10M50.21M46.61M40.03M164.64M181.13M162.59M118.39M121.56M122.51M
Total Equity1.81M19.55M22.71M31.35M145.82M145.22M130.09M103.52M98.69M79.72M
Cash1.22M2.21M3.04M6.59M32.67M29.76M26.80M20.07M23.96M15.99M
Total Debt5.09M19.54M18.56M15.48M63.31M69.44M69.78M62.12M62.47M59.78M
Net Debt3.87M17.33M20.51M8.88M30.63M39.68M42.98M42.05M38.51M43.79M

Cash Flow

Currency: GBP2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.72M6.38M4.41M10.59M-755.25K19.75M5.08M12.66M7.20M93.00K
Investing Cash Flow-77.77K-37.95M-54.48K-2.91M-117.42M-15.66M-4.19M-6.18M-2.52M-2.65M
Financing Cash Flow-243.12K32.60M-3.76M-4.04M136.53M1.26M-4.40M-8.84M-426.00K-4.85M
Capital Expenditure77.77K1.29M974.99K2.92M2.62M7.64M4.24M5.75M2.92M2.35M
Free Cash Flow1.64M5.10M3.44M7.67M-3.37M12.37M842.00K6.92M4.28M-2.26M
Dividends Paid---1.57M1.57M1.57M1.57M---
FCF to OCF95.47%79.85%77.91%72.40%445.82%62.65%16.58%54.60%59.44%-2427.96%
Dividend Paid to FCF---20.50%-46.69%12.71%186.70%---

Key Statistics & Ratios

Market Cap99.89M
Enterprise Value130.99M
Trailing P/E0.00
Forward P/E11.36
Price / Sales0.52
Price / Book1.17
EPS-0.04
Book Value0.784
Revenue (TTM)193.23M
Gross Profit (TTM)100.88M
EBITDA14.74M
Profit Margin-2.81%
Operating Margin5.95%
Return on Equity-4.18%
Return on Assets2.72%
Shares Outstanding109.17M
Shares Float11.84M
Beta1.61
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.66%

Dividends

20221×
0.01Sep 1, 2022